Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study of pembrolizumab and usual treatment for cervical cancer (The Papaya Study)
This study looked at whether pembrolizumab could improve treatment for cancer of the cervix.
More about this trial
- see if adding pembrolizumab to standard treatment keeps the cancer under control for longer
- learn more about the side effects
Summary of results
It was difficult to get enough women to join the trial. So the trial was never finished and there are no results available.
How to join a clinical trial
Dr Susan Lalondrelle
Biomedical Research Centre (BRC)
Merck, Sharpe & Dohme
Royal Marsden NHS Foundation Trust